The double intervention clinical value and application research of TACE with PAI on massive hepatocellular carcinoma

Chinese-German Journal of Clinical Oncology

Volumn 7, Issue 3, 2008, Pages 128-130

  Liu, Sibin ^a   Hu, Daoyu ^a   Huang, Yuanyi ^a   Rao, Dinghu ^a   Zhou, Wenhui ^a   Liu, Jiangze ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hepatocarcinoma; Percutaneous acetic acid injection; Transcatheter arterial chemoembolization

Indexed keywords

EID: 42549109409     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-007-0199-9     Document Type: Article

References (7)

1. Zhu KS, Shan H, Huang MS, et al. The content changes of serum liver fibrosis indicators after transarterial chemoembolization for primary hepatic carcinoma and their clinical significance. J Clin Radiol (Chinese), 2000, 19: 208-210.
2. Lu W, Li YH, Li ZG, et al. A comparative study on necrosis and apoptosis of hepatocellular carcinoma cells after TACE with use of low-dose and conventional-dose anticancer drugs. Chin J Radiol (Chinese), 2003, 37: 232-234.
3. Hu DY, Li Z, Wang N, et al. TACE treatment of hepatic carcinoma: A comparative study of low dose versus conventional dose. J Clin Radiol (Chinese), 2004, 23: 502-506.
4. Ohnishi K, Ohyama N, Ito S, et al. Small hepatocellular carcinoma: treatment with us-guided intratumoral injection of acetic acid. Radiology, 1994, 193: 747-752.
5. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer, 1992, 69: 925-929.
6. Lu GR, Li XF, Wang JY, et al. Treatment of liver cancer by percutaneous injection of acetic acid under ultrasound guidance. Chin J Ultrason (Chinese), 1999, 8: 229-231.
7. Zhou YC, Yang HF, Zhang JX, et al. Preliminary report of the chemo-ablation of hepatic neoplasms. Radiol Pract (Chinese), 2001, 16: 73-75.